Condition: Pituitary Adenoma · Sponsor: University of Cambridge
The goal of this single centre pilot study is to explore whether 18F-fluoro-ethyl-tyrosine PET (FET-PET) yields comparable findings to 11C-methionine PET (Met-PET) for the localisation of pituitary tumours.
This description comes directly from the study's public registry record.
James MacFarlane · 01223 250882 · jm2267@medschl.cam.ac.uk
Always discuss trial participation with your own doctor first.
| Cambridge University Hospitals | Cambridge, Cambridgeshire, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06584123